The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,119,469 in first-year total cost, median $734,665.
Most frequent study sections
- HIV Coinfections and HIV Associated Cancers Study Section[HCAC]1
- Special Emphasis Panel[ZRG1 AARR-P (02)]1
- Special Emphasis Panel[ZRG1 IDIB-B (02)]1
Most frequent institutions
- EMORY UNIVERSITY1
- UNIVERSITY OF PITTSBURGH AT PITTSBURGH1
- WASHINGTON UNIVERSITY1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2022 | Elucidating the mechanisms and consequences of MDSC-regulated immunity in TB1R01AI164970-01A1 | BRYSON, BRYAN DAVIDMATTILA, JOSHUA T.ROBINSON, CORY MICHAEL | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $547,847 | ZRG1 |
| 2021 | Synthetic Nanoparticle-antibody (SNAb) Based Depletion of Myeloid-Derived Suppressor Cells for TB Host-Directed Therapy1R01AI155023-01A1 | RENGARAJAN, JYOTHIROY, KRISHNENDU | EMORY UNIVERSITY, GA | $836,957 | HCAC |
| 2020 | Understanding the functional role of Myeloid Derived Suppressor cells in tuberculosis1R01AI155024-01 | KAUSHAL, DEEPAKKHADER, SHABAANA A. | WASHINGTON UNIVERSITY, MO | $734,665 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.